Schedule 13G ownership disclosure

ProQR Therapeutics NV

Security class unavailable · CUSIP: N71542109

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,578,174
Percent of class
6.7600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001425738-17-000008
Form type
SC 13G
Filer
ProQR Therapeutics N.V.
CIK
CIK 1612940
Filed
Feb 14, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub